门冬胰岛素30和精蛋白生物合成人胰岛素30R治疗2型糖尿病的成本-效果分析
赵雪, 孙利华
Cost-Effectiveness Analysis of Insulin Aspart30 Versus Premixed Human Insulin 30/70 in Patients with Type 2 Diabetes in China
ZHAO Xue, SUN Li-hua
中国药学杂志
.
2016, (21): 1895
-1900
.
DOI: 10.11669/cpj.2016.21.014
